Evaluating the Individualized Treatment of Traditional Chinese Medicine: A Pilot Study of N-of-1 Trials

Haiyin Huang, Peilan Yang, Jingjing Xue, Jie Tang, Liyu Ding, Ying Ma, Jie Wang, Gordon H Guyatt, Thuva Vanniyasingam, Yuqing Zhang, Haiyin Huang, Peilan Yang, Jingjing Xue, Jie Tang, Liyu Ding, Ying Ma, Jie Wang, Gordon H Guyatt, Thuva Vanniyasingam, Yuqing Zhang

Abstract

Purpose. To compare the efficacy of individualized herbal decoction with controlled decoction for individual patients with stable bronchiectasis. Methods. We conducted N-of-1 RCTs (single-patient, double-blind, randomized, multiple crossover design) in 3 patients with stable bronchiectasis. The primary outcome was patient self-rated symptom scores on visual analogue scales. Secondary outcome was 24-hour sputum volume. A clinical efficacy criterion which combined symptoms score and medication preference was also formulated. Results. All three patients showed various degrees of improvement on their symptoms and one patient's (Case 3) 24 h sputum volume decreased from 70 mL to 30 mL. However, no significant differences were found between individualized herbal decoction and control decoction on symptoms score, or on 24-hour sputum volume. One patient (Case 2) had clear preference for the individualized herbal decoction over the standard one with the confirmation after unblinding. We therefore considered this case as clinically important. Discussion. N-of-1 trials comply with individualized philosophy of TCM clinical practice and had good compliance. It is necessary to set up clinical efficacy criteria and to consider the interference of acute exacerbation.

Figures

Figure 1
Figure 1
The flow chart of the N-of-1 trials in the treatment of stable bronchiectasis by traditional Chinese medicine based on syndrome differentiation.
Figure 2
Figure 2
The flow chart of the whole process including recruitment, enrollment, and completion of the pilot study.

References

    1. Guyatt G. H., Keller J. L., Jaeschke R., et al. The n-of-1 randomized controlled trial: clinical usefulness. Annals of Internal Medicine. 1990;112(4):293–299.
    1. Jørgensen J. T. New era of personalized medicine: a 10-year anniversary. Oncologist. 2009;14(5):557–558. doi: 10.1634/theoncologist.2009-0047.
    1. Hu S. X., Foster T., Kieffaber A. Pharmacogenomics and personalized medicine: mapping of future value creation. Biotechniques. 2005;39(10):S1–S6.
    1. Huang H. Y., Yang P. L., Zhang Y. Q., Xue J. J., Xu M. H. Potential value and feasibility of N-of-1 randomized controlled trials in research of traditional Chinese medicine. Shanghai Journal of Traditional Chinese Medicine. 2012;46(8):3–8.
    1. Liu J. P., Zhang M., Yang M., et al. The application of the design of N-of-1 randomized controlled trials in research of traditional Chinese medicine. Chinese Journal of Information on Traditional Chinese Medicine. 2002;9(6):66–68.
    1. Pasteur M. C., Bilton D., Hill A. T. British thoracic society guideline for non-CF bronchiectasis. Thorax. 2010;65(supplement 1):i1–i58. doi: 10.1136/thx.2010.136119.
    1. The writing group of consensus of the experts on the diagnosis and treatment of bronchiectasis. Consensus of the experts on the diagnosis and treatment of bronchiectasis. Zhonghua Jie He He Hu Xi Za Zhi. 2013;36(8):563–566.
    1. Huang H. Y., Yang P. L., Tang J., et al. Long term effect of the treatment method of strengthening vital Qi, transforming Phlegm and clearing heat for 46 cases of bronchiectasis. Journal of Traditional Chinese Medicine. 2012;53(10):848–852.
    1. Mei L., He X., Xiong Y., Shi K., Lin Y., Hu C. Study of antibacterial activities test in serum of Scutellaria Baicalensis Georgi. Journal of Medical Research. 2009;38(1):102–103.
    1. Mi W., Wang Z.-Q., Qiu S.-C., Du Z.-Z., Liu X.-B. The in vitro growth inhibitory effect of radix arnebiae lithospermi (RAL) on bacteria. Lishizhen Medicine and Materia Medica Research. 2007;18(9):2217.
    1. Zhaosheng H. Science of Chinese Materia Medica. 7th. Beijing, China: People's Medical Publishing House; 2006.
    1. The State Administration of Traditional Chinese Medicine . Criteria of Diagnosis and Therapeutic Effect of TCM Diseases. Nanjing, China: Nanjing University Press; 1994.
    1. Zhang H. Y., Li X., Ni W., Chen F., Shao C. Chinese medical syndrome differentiation laws of bronchiectasis. Shanghai Journal of Traditional Chinese Medicine. 2005;39(1):16–18.
    1. Lu L. The comparative study of traditional and modern boil medicine methods. China Medicine and Pharmacy. 2012;2(18):45–46.
    1. Guyatt G., Sackett D., Adachi J., et al. A clinician’s guide for conduction randomized trials in individual patients. Canadian Medical Association Journal. 1988;139:497–503.
    1. Thabane L., Ma J., Chu R., Cheng J., Ismaila A., Rios L. P., Robson R., Thabane M., Giangregorio L., Goldsmith C. H. A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology. 2010;10, article 1 doi: 10.1186/1471-2288-10-1.
    1. Nonoyama M. L., Brooks D., Guyatt G. H., Goldstein R. S. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. American Journal of Respiratory and Critical Care Medicine. 2007;176(4):343–349. doi: 10.1164/rccm.200702-308OC.
    1. Wang H., Chen J., Shang, H.-C. Exploration and practice of N-of-1 trial design in clinical research of TCM. Chinese Journal of Traditional Chinese Medicine. 2008;33(3):229–232.
    1. Da-jun Y., Wei-liang W., Fang L. Randomized controlled trials in individual patient of third stage of chronic kidney disease. Journal of Traditional Chinese Medicine. 2012;53(3):222–224.
    1. Zhang X., Huang L.-F., Li X. Randomized controlled trials in individual pantient of third stage of hypertension intracerebral hemorrhage. Journal of Zhejiang University of TCM. 2012;36(8):871–886.
    1. Yuhong H., Qian L., Yu L., et al. An n-of-1 trial service in clinical practice: testing the effectiveness of Liuwei Dihuang decoction for Kidney-Yin deficiency syndrome. Evidence-Based Complementary and Alternative Medicine. 2013;2013 doi: 10.1155/2013/827915.827915
    1. Jiang Z., Liu J., Ge F., Liu J. Application and consideration of placebo in clinical trial researches of new traditional Chinese medicine. Clinical Trial Researches of New Traditional Chinese Medicine. Modern Chinese Medicine. 2013;15(6):464–466.
    1. Xie Z. J., Wen C. P., Fan Y. S. Discussion on quality control of randomized, double-blind and placebo controlled clinical trial of Chinese medicine. CJTCMP. 2012;27(6):1479–1481.
    1. Xiao X. H., Dan Y., Cheng J., et al. Increasing dosage: a momentous proposition to improve therapeutic eficacy of traditional Chinese medicine. China Journal of Chinese Materia Medica. 2008;33(3):229–232.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner